Pelitinib (EKB‐569) targets the up‐regulation of ABCB1 and ABCG2 induced by hyperthermia to eradicate lung cancer

Publisher: John Wiley & Sons Inc

E-ISSN: 1476-5381|172|16|4089-4106

ISSN: 0007-1188

Source: BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.172, Iss.16, 2015-08, pp. : 4089-4106

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract